Linden Capital Partners Welcomes Dr. Auro Nair as Operating Partner
Chicago, Illinois (May 2, 2025) – Linden Capital Partners (“Linden”), a Chicago-based private equity firm focused exclusively on healthcare, today announced that Dr. Auro Nair has joined the firm as an Operating Partner. Dr. Nair brings more than 30 years of experience across the biopharmaceutical, life sciences, and biomedical research industries, further strengthening Linden’s capabilities within drug discovery, pre-clinical research, and pharma services.
Dr. Nair served as Executive Vice President of The Jackson Laboratory (JAX), a leading biomedical research institution, and also served as President of JAX’s Mice, Clinical & Research Services business. During his tenure, Dr. Nair led strategic growth initiatives across the organization, supporting drug discovery and the development of precision medicine platforms. Earlier in his career, he held leadership roles at Caliper Life Sciences and Glaxo. He currently serves on the board of the Institute for Protein Innovation and CellBio Scientific and is a board member at BioIVT, a Linden portfolio company.
“I’m thrilled to join Linden and work alongside such a talented team dedicated to building and scaling healthcare companies,” said Dr. Nair. “Linden’s values, value creation focus, and long-term approach to partnership strongly align with my own. I look forward to supporting the existing portfolio companies and helping identify new opportunities in the pharma services and life science tools ecosystem.”
“We are excited to welcome Auro to the Linden team,” said Piyush Shukla, Partner at Linden. “His leadership of complex, research-driven organizations and his deep domain experience in drug discovery, development, and pre-clinical research make him an ideal Operating Partner for Linden. Auro has already made significant contributions through his board role at BioIVT, and we’re confident he will continue to play a critical role in advancing our investment strategy in this important segment of the healthcare ecosystem.”
Dr. Nair holds a Ph.D. in Chemistry from the University of Oklahoma, an Executive MBA from Suffolk University, and a Bachelor of Science in Chemistry from Universiti Sains Malaysia.
About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on the healthcare industry. Founded in 2004, Linden is the largest dedicated healthcare private equity firm. Linden’s strategy is based upon three elements: (i) healthcare specialization, (ii) integrated private equity and operating expertise, and (iii) its differentiated human capital program. Since its founding, Linden has invested in over 45 healthcare companies encompassing over 350+ total transactions across its strategies. The firm currently manages over $13.0 billion of regulatory assets under management. For more information, please visit www.linden.com.